About the Cover

Oncology

• Basic Science

  • FEATURED BASIC SCIENCE ARTICLE

    • You have access

      Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist

      Hanwen Zhang, Pooja Desai, Yusuke Koike, Jacob Houghton, Sean Carlin, Nidhi Tandon, Karim Touijer and Wolfgang A. Weber

      Journal of Nuclear Medicine January 1, 2017, 58 (1) 29-35; DOI: https://doi.org/10.2967/jnumed.116.176099
  • You have access

    Effect of Carbidopa on ¹⁸F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging

    Julien Detour, Alice Pierre, Fréderic Boisson, Guillaume Kreutter, Thomas Lavaux, Izzie Jacques Namer, Laurence Kessler, David Brasse, Patrice Marchand and Alessio Imperiale

    Journal of Nuclear Medicine January 1, 2017, 58 (1) 36-41; DOI: https://doi.org/10.2967/jnumed.116.180588
  • You have access

    Metabolic Evaluation of Non–Small Cell Lung Cancer Patient–Derived Xenograft Models Using ¹⁸F-FDG PET: A Potential Tool for Early Therapy Response

    Silvia Valtorta, Massimo Moro, Giovanna Prisinzano, Giulia Bertolini, Monica Tortoreto, Isabella Raccagni, Ugo Pastorino, Luca Roz, Gabriella Sozzi and Rosa Maria Moresco

    Journal of Nuclear Medicine January 1, 2017, 58 (1) 42-47; DOI: https://doi.org/10.2967/jnumed.116.176404

• Translational Science

  • You have access

    Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate ¹⁷⁷Lu-Lilotomab Satetraxetan

    Johan Blakkisrud, Ayca Løndalen, Anne C.T. Martinsen, Jostein Dahle, Jon E. Holtedahl, Tore Bach-Gansmo, Harald Holte, Arne Kolstad and Caroline Stokke

    Journal of Nuclear Medicine January 1, 2017, 58 (1) 48-54; DOI: https://doi.org/10.2967/jnumed.116.173922
  • You have access

    Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with ¹⁷⁷Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate

    Johan Blakkisrud, Ayca Løndalen, Jostein Dahle, Simon Turner, Harald Holte, Arne Kolstad and Caroline Stokke

    Journal of Nuclear Medicine January 1, 2017, 58 (1) 55-61; DOI: https://doi.org/10.2967/jnumed.116.180471

• Clinical Investigation

  • You have access

    ¹⁸F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine–Rituximab

    Dominick Lamonica, Daniel A. Graf, Mihaela C. Munteanu and Myron S. Czuczman

    Journal of Nuclear Medicine January 1, 2017, 58 (1) 62-68; DOI: https://doi.org/10.2967/jnumed.116.173542
  • You have access

    Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma

    Jacob H. Rasmussen, Martin Nørgaard, Adam E. Hansen, Ivan R. Vogelius, Marianne C. Aznar, Helle H. Johannesen, Junia Costa, Astrid M.E. Engberg, Andreas Kjær, Lena Specht and Barbara M. Fischer

    Journal of Nuclear Medicine January 1, 2017, 58 (1) 69-74; DOI: https://doi.org/10.2967/jnumed.116.180091